Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer - Von Der Maase, H; Sengelov, L; Roberts, JT (J Clin Oncol, 2005)
et al.